Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P353: Aberrant brain structural large-scale connectome in Crohn’s disease

ECCO '19 Copenhagen

Year: 2019
Authors:

A. Thomann*1, M. Griebe2, M. Ebert1, P. Thomann3, W. Reindl1

1Medical faculty Mannheim, Heidelberg University, Department of Medicine II, Mannheim, Germany, 2Medical faculty Mannheim, Heidelberg University, Department of Neurology, Mannheim, Germany, 3Odenwald District Healthcare Center, Center for Mental Health, Erbach, Germany

P354: Perceived Quality of Care is associated to quality of life, work productivity and gender but not disease phenotype: a prospective study in a high-volume IBD centre

ECCO '19 Copenhagen

Year: 2019
Authors:

L. Gonczi*1, Z. Kurti1, C. Verdon2, J. Reinglas2, R. Kohen2, I. Morin2, K. Chavez2, T. Bessissow2, W. Afif2, G. Wild2, E. Seidman2, A. Bitton2, P. Lakatos2

1Semmelweis University, First Department of Internal Medicine, Budapest, Hungary, 2McGill University Health Center, Division of Gastroenterology, Montreal, Canada

P355: Diagnostic accuracy and usability of home calprotectin testing

ECCO '19 Copenhagen

Year: 2019
Authors:

A. Thomas*1, M. Clarke1, V. Cairns1, J. Goodhand1, T. Ahmad1, N. Kennedy1

1Royal Devon and Exeter Hospital, Gastroenterology, Exeter, UK

P356: Safety and effectiveness of granulocyte and monocyte adsorptive apheresis in paediatric patients with inflammatory bowel disease: a multi-centre cohort study

ECCO '19 Copenhagen

Year: 2019
Authors:

N. Toita*1, H. Tanaka2, K. Arai3, H. Shimizu3, D. Abukawa4, T. Kobayashi5, N. Yoshimura6, S. Tanida7, E. Hosoi8

1Sapporo Kosei General Hospital, Department of Pediatrics, Sapporo, Japan, 2Sapporo Kosei General Hospital, IBD Center, Sapporo, Japan, 3National Center for Child Health and Development, Division of Gastroenterology, Setagaya, Japan, 4Miyagi Children's Hospital, Department of General Pediatrics, Sendai, Japan, 5Hakodate Goryoukaku Hospital, Department of Gastroenterology, Hakodate, Japan, 6Tokyo Yamate Medical Center, Department of Internal Medicine, Division of IBD, Shinjuku, Japan, 7Nagoya City University, Graduate School of Medical Sciences, Department of Gastroenterology and Metabolism, Nagoya, Japan, 8JIMRO Co., Ltd., MA, Takasaki, Japan

P357: Serological biomarkers of interstitial matrix and basement membrane remodelling correlate to disease activity in Crohn’s disease

ECCO '19 Copenhagen

Year: 2019
Authors:

L. Godskesen1, M. Lindholm2, J. Høg Mortensen2, A. Krag1, M. Karsdal2, T. Manon-Jensen2, J. Kjeldsen1

1Odense University Hospital, Department of Medical Gastroenterology, Odense, Denmark, 2Nordic Bioscience, Biomarkers and Research, Herlev, Denmark

P358: Ustekinumab is effective for the treatment of chronic antibiotic-refractory pouchitis

ECCO '19 Copenhagen

Year: 2019
Authors:

J. E. Ollech*1, L. Glick1, R. Weisshof1, A. Israel1, K. El Jurdi1, N. Krugliak Cleveland1, R. D. Cohen1, S. R. Dalal1, D. T. Rubin1

1Inflammatory Bowel Disease Center, University of Chicago Medicine, Chicago, USA

P359: Budesonide MMX in paediatric ulcerative colitis

ECCO '19 Copenhagen

Year: 2019
Authors:

M. Meglicka*1, M. Dadalski1, A. Adamczuk1, J. Kierkus1

1The Children’s Memorial Health Institute, Department of Gastroenterology, Hepatology, Feeding Disorders and Paediatrics, Warsaw, Poland

P360: Inflammatory microheterogeneity in ulcerative colitis: implications for microscopic assessment of disease activity

ECCO '19 Copenhagen

Year: 2019
Authors:

N. Harpaz1,2, S. Ballentine1, B. E. Sands2, J-F. Colombel2, H. M. Ko*1,2

1Icahn School of Medicine at Mount Sinai, Department of Pathology, New York, USA, 2Icahn School of Medicine at Mount Sinai, Department of Medicine, Gastroenterology, New York, USA

P361: Laboratory criteria of infliximab therapy inefficiency in children with IBD

ECCO '19 Copenhagen

Year: 2019
Authors:

A. Potapov*1, T. Radigina2, S. Petrichuk2, D. Gerasimova2, A. Illarionov1,3, A. Anushenko1, T. Erlikh-Fox4

1National Medical Research Center for Children's Health, Gastroenterology and Hepatology, Moscow, Russian Federation, 2National Medical Research Center for Children's Health, Laboratory of Experimental Immunology and Virology, Moscow, Russian Federation, 3Sechenov First Moscow State Medical University, Department of Peliatrics and Rheumatology, Moscow, Russian Federation, 4National Medical Research Center for Children's Health, Cytochemical Research Center, Moscow, Russian Federation

P362: Faecal calprotectin is an early predictor of endoscopic response and histological remission after the start of vedolizumab

ECCO '19 Copenhagen

Year: 2019
Authors:

R. W. M. Pauwels*1, A. C. de Vries1, J. C. Goet1, N. S. Erler2, C. J. van der Woude1

1Erasmus MC, Department of Gastroenterology and Hepatology, Rotterdam, The Netherlands, 2Erasmus MC, Department of Biostatistics, Rotterdam, The Netherlands

P363: The minimal invasive surgery in combination with negative pressure wound therapy for perianal fistulas in Crohn’s colitis lead to the fast introduction of the biological treatment and improve the results

ECCO '19 Copenhagen

Year: 2019
Authors:

T. Banasiewicz*1, J. Paszkowski1, J. Hermann1, J. Cwalinski1, P. Eder2, K. Stawczyk-Eder2, K. Waszak2, A. Dobrowolska2

1University of Medical Sciences, General, Endocrinological Surgery and Gastrointestinal Oncology, Poznań, Poland, 2University of Medical Sciences, Department of Gastroenterology, Poznan, Poland

P364: The value of faecal calprotectin for assessing endoscopic activity and predicting future clinical course in patients with active ulcerative colitis treated with granulomonocytapheresis: a prospective study

ECCO '19 Copenhagen

Year: 2019
Authors:

T. Shimoyama*1, T. Yamamoto1, S. Umegae1, K. Matsumoto1

1Yokkaichi Hazu Medical Centre, IBD Centre, Yokkaichi, Japan

P365: Autologous haematopoietic stem cell transplantation in refractory Crohn’s disease: experience of a Brazilian tertiary centre

ECCO '19 Copenhagen

Year: 2019
Authors:

J. Oba*1,2, F. Steinwurz2, A. Scanavini Neto3, O. Ambrogini4, C. Silva5, S. Nakashima5, M. Santos5, N. Hamerschlak6

1São Paulo University Medical School, Pediatric, São Paulo, Brazil, 2Hospital Israelita Albert Einstein, GI, São Paulo, Brazil, 3Hospital Israelita Albert Einstein, Surgery, São Paulo, Brazil, 4UNIFESP-EPM, GI, SP, Brazil, 5Hospital Israelita Albert Einstein, Research, São Paulo, Brazil, 6Hospital Israelita Albert Einstein, Oncology-hematology, São Paulo, Brazil

P366: A service evaluation of pre-operative nutritional optimisation in patients with Crohn’s disease using exclusive enteral nutrition with or without supplementary parenteral nutrition

ECCO '19 Copenhagen

Year: 2019
Authors:

D. O'Hanlon1, A. Sandall1,2, A. Darakhshan3, A. Williams3, E. Westcott3, K. Patel4, P. Irving4, M. Lomer1,2

1Guy's and St.Thomas' NHS Foundation Trust, Nutrition and Dietetics, London, UK, 2King's College London, Nutritional Sciences Division, London, UK, 3Guy's and St. Thomas' NHS Foundation Trust, Colorectal Surgery, London, UK, 4Guy's and St. Thomas' NHS Foundation Trust, Gastroenterology, London, UK

P367: Nutrition advice for IBD patients as a useful complementary strategy: a single-centre cohort intervention

ECCO '19 Copenhagen

Year: 2019
Authors:

M. Fortuna1, M. Di Ruscio*1, A. Variola1, A. Massella1, A. Geccherle1

1Multispecialistic Centre for Recto-Perineal Diseases (IBD Unit), Department of Gastroenterology, IRCCS Ospedale Sacro Cuore Don Calabria, Negrar (Verona), Italy

P368: Vedolizumab in inflammatory bowel disease: a retrospective single-centre study

ECCO '19 Copenhagen

Year: 2019
Authors:

C. Larsson*1, M. Henriksen1, L-P. Jelsness-Jørgensen1,2, A. Rekvin3, F. Lerang1

1Hospital Sykehuset Østfold, Department of Gastroenterology, Sarspborg, Norway, 2Østfold University College, Halden, Norway, 3Hospital Sykehuset Østfold, Department of Research, Sarspborg, Norway

P369: The comparative frequency of clostridial infection in patients with ulcerative colitis receiving mesenchymal stromal cells and anti-cytokine therapy

ECCO '19 Copenhagen

Year: 2019
Authors:

O. Knyazev1, A. Kagramanova*1, M. Chernova2, I. Korneeva1, D. Kulakov1, A. Parfenov1

1Moscow Clinical Scientific Center named after A. S. Loginov, Department of inflammatory bowel diseases, Moscow, Russian Federation, 2Moscow Clinical Scientific Center named after A. S. Loginov, Infection department, Moscow, Russian Federation

P370: Quality of life of patients with inflammatory bowel diseases in remission on different forms of treatment

ECCO '19 Copenhagen

Year: 2019
Authors:

A. Kalaba*1, M. Markovic2, M. Jankovic1, D. Zaric1, S. Markovic1, P. Svorcan1

1Clinical Center Zvezdara, Department of Gastroenterology, Belgrade, Serbia, 2Institute of Public Health of Belgrade, Health Promotion, Belgrade, Serbia

P371: Outcome of immediate infliximab optimisation based on rapid assessment of serum drug and faecal calprotectin concentrations in Crohn’s disease

ECCO '19 Copenhagen

Year: 2019
Authors:

K. Farkas*1, K. Szántó1, D. Kata2, A. Bálint1, Á. Milassin1, A. Fábián1, R. Bor1, M. Rutka1, Z. Szepes1, I. Soós1, F. Nagy1, I. Földesi2, T. Molnár1

1University of Szeged, First Department of Medicine, Szeged, Hungary, 2University of Szeged, Institute of Laboratory Medicine, Szeged, Hungary

P372: Neurological symptoms and imaging abnormalities in brain MRI in patients with Crohn’s disease receiving anti-TNFa therapy

ECCO '19 Copenhagen

Year: 2019
Authors:

M. Papatheodoridi*1, A. Euthumiou2, N. Perlepe3, F. Gagas3, M. Gizis3, S. Lagou3, G. Kounadis3, J. Koutsounas3, G. Bamias3

1GI Unit, 3rd Academic Department of Internal Medicine, Athens, Greece, 2General Hospital ‘Laikon’, Neurological Unit,, Athens, Greece, 3Sotiria Hospital, National and Kapodistrian University of Athens, GI-Unit, 3rd Academic Department of Internal Medicine, Athens, Greece